Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study

Intensive Care Med. 2016 Oct;42(10):1588-1596. doi: 10.1007/s00134-016-4356-x. Epub 2016 May 11.

Abstract

Purpose: Prospective data on potential factors associated with severity of imported Plasmodium falciparum malaria are lacking. We evaluated whether several host- and parasite-related biomarkers may improve early severity evaluation.

Methods: Prospective multicenter observational study comparing uncomplicated and severe imported falciparum malaria in adults conducted in France in 52 units, from 2007 to 2010. Association of several host- and parasite-related biomarkers with severity of malaria was tested using univariate and multivariate analyses.

Results: Of 295 patients, 140 had uncomplicated malaria and 155 severe malaria (including very severe and less severe cases according to predefined criteria). Curative intravenous quinine treatment was used in 154/155 patients with severe malaria and atovaquone/proguanil in 74 % of patients with uncomplicated malaria. Hospital mortality was 5.2 % (8 patients), all in the severe malaria group. Among host-related biomarkers, CRP, procalcitonin, and sTREM-1 were significantly higher and albumin was significantly lower in severe versus uncomplicated malaria; only the last three biomarkers also differed significantly between the very and less severe malaria groups. Among parasite-related biomarkers, only plasma PfHRP2 was significantly higher in severe versus uncomplicated malaria and in very severe versus less severe malaria; parasitemia did not differ between very and less severe malaria. By multivariate analysis, only lower plasma albumin and higher sTREM-1 were associated with greater severity, with intermediate accuracies.

Conclusions: During imported malaria, the most useful biomarkers associated with severity seem to be plasma albumin and sTREM-1; and among parasite-related parameters, PfHRP2 was more strongly associated with severity than parasitemia was.

Keywords: Biomarkers; Intensive care; Malaria; Parasitemia; PfHRP2; Quinine.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Adult
  • Analysis of Variance
  • Animals
  • Antigens, Protozoan / blood*
  • Antimalarials / therapeutic use*
  • Atovaquone / therapeutic use
  • Biomarkers / blood
  • C-Reactive Protein / analysis
  • Calcitonin / blood
  • Drug Combinations
  • Female
  • France
  • Host-Parasite Interactions
  • Humans
  • Malaria, Falciparum / blood*
  • Malaria, Falciparum / drug therapy*
  • Malaria, Falciparum / parasitology
  • Male
  • Middle Aged
  • Parasitemia / blood
  • Plasmodium falciparum*
  • Proguanil / therapeutic use
  • Prospective Studies
  • Protozoan Proteins / blood*
  • Quinine / therapeutic use*
  • Severity of Illness Index*

Substances

  • Antigens, Protozoan
  • Antimalarials
  • Biomarkers
  • Drug Combinations
  • HRP-2 antigen, Plasmodium falciparum
  • Protozoan Proteins
  • atovaquone, proguanil drug combination
  • Calcitonin
  • C-Reactive Protein
  • Quinine
  • Proguanil
  • Atovaquone